norstella

Private

Last Round

Buyout/LBO

Nov 1, 2022

Est. Valuation

$5B

Total Funding Raised

Company Overview

Provider of pharmaceutical intelligence solutions and consultancy services for the life sciences industry.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Related companies by embedding similarity.

Access detailed peer comparisons, multiples, and valuation benchmarks.

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Buyout/LBO	Nov 1, 2022

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about norstella's valuation, stock price, and market status.

Headquarters—

Year Founded2022

Last FundingNov 1, 2022

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.